MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference
NEW YORK--(BUSINESS WIRE)--$MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announc